Peter Attia· MD
on the lipoprotein side we can see most of what we want which is the LP little-a the LDL the small LDL I'm talking particle number not cholesterol and the VLDL
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
on the lipoprotein side we can see most of what we want which is the LP little-a the LDL the small LDL I'm talking particle number not cholesterol and the VLDL
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the two things we care most about here are apob and LP little a